Antimicrobial changes made for suspected infectious diarrhea after positive gastrointestinal pathogen panel result
Around one-third of patients with a positive GIP test experienced a change in antimicrobials, and most of these changes were guideline-adherent. Most GIP tests ordered during the study period were negative, and most positive tests did not require antimicrobial therapy.
Authors
- Samantha Eiffert (ORCID: https://orcid.org/0000-0002-8612-3807)
- Natalie A Mackow (ORCID: https://orcid.org/0000-0001-7212-3833)
- Madison Ponder (ORCID: https://orcid.org/0000-0002-4933-7216)
- Melissa B. Miller (ORCID: https://orcid.org/0000-0002-0296-3535)
- Luther A. Bartelt (ORCID: https://orcid.org/0000-0002-7596-4272)
- Banks W Kooken (ORCID: https://orcid.org/0000-0003-3188-2598)
- Alan C. Kinlaw (ORCID: https://orcid.org/0000-0002-4279-8685)
- Emily J. Ciccone (ORCID: https://orcid.org/0000-0003-2445-8473)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10184
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Center for Advancing Translational Sciences
- School of Medicine, University of North Carolina at Chapel Hill
- North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill